Oxford Nanopore Technologies, the company delivering a new generation of molecular sensing technology based on nanopores, and ...
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies today announced the expansion of its Compatible Products Programme (CPP), welcoming a new cohort of leading partners whose products now ...
Nanopore sequencing offers comparable accuracy to short-read NGS for IGH clonotyping in CLL, with advantages in cost and laboratory footprint. The study confirms reliable somatic hypermutation status ...
ViruSure, an Asahi Kasei company and global leader in pathogen safety testing for biopharmaceuticals, today announced the launch of the world's first GMP-validated adventitious viral agent (AVA) ...
Cell and gene therapies are rapidly becoming a staple of the therapeutic landscape for a range of diseases. Recent improvements in the accuracy, read length, and throughput offered by Oxford Nanopore ...
With any-length reads of DNA and RNA, from short to ultra-long, you can finally characterize the full diversity of our microbial world. In this White Paper, find out how nanopore sequencing is ...
Funding from agencies such as the National Science Foundation, the National Institutes of Health, NASA and many more help ensure the United States remains at the forefront of discoveries in health, ...
Barclays 28th Annual Global Healthcare Conference March 11, 2026 3:30 PM EDTCompany ParticipantsNicholas Keher ...
Following on from the recent official launch of BGI’s new CycloneSEQ™ is the first independently reviewed benchmarking data. The CycloneSEQ™ platform delivers long-reads using novel nanopore ...
Good morning, and welcome to our 2024 full results. I'm Gordon Sanghera, Chief Executive of Oxford Nanopore, and I'm joined today by our CFO, Nick Keher. This March marks 20th anniversary of Oxford ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results